Secrets of Strixhaven is Magic’s next set, and it’s back to a beloved Plane from Magic’s past. While the legendary wizarding school (no, not that one) is opening its doors again, it’s also introducing ...

The View‘s Hot Topics Table may be cooling down this week, but fortunately, things are set to heat up soon. Loyal viewers of The View have likely noticed by now that reruns of the ABC daytime talk ...

If you’re hoping to take a little time to enjoy “The View” this week, you still can, but just know, they won’t be new episodes. The ABC talk show is officially on hiatus, but don’t worry, it’s a very ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

Combo Devils, a recently kickstarted platform fighter from developer Punkzilla, has one of the best elevator pitches of any fighting game I’ve played in a hot minute: What if we took the core of Smash ...

Add Sporting News as a preferred source on Google to see more of our reporting Add as preferred source on Google Jeff Hauser is a freelance writer with The Sporting News. He has over twenty years of ...

From Savannah Chrisley to Elisabeth Hasselbeck, "The View" has made room for a slew of guest co-hosts in recent weeks, and this week won't be any different. Joining Whoopi Goldberg, Joy Behar, Sunny ...

Hoppers Just Had Pixar's Best Debut For An Original Movie In Years, But The Box Office Wasn't Nearly As Kind To The Bride! And Scream 7 GOAT Takes Down Wuthering Heights At The Box Office With An ...

Many pundits believe the slasher pic will make franchise history in besting the $44.4 million domestic launch of the last installment. Globally, the movie is eyeing a $60 million start. By Pamela ...

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. Chalk up another new potential expansion for Lilly as it has ...

Researchers conducted a phase 2b randomized trial to examine the efficacy, safety, and pharmacokinetics of a twice-daily single-pill bictegravir/emtricitabine ...